Freestone Capital Holdings LLC Raises Holdings in Intuitive Surgical, Inc. $ISRG

Freestone Capital Holdings LLC boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 90.1% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 13,800 shares of the medical equipment provider’s stock after purchasing an additional 6,540 shares during the quarter. Freestone Capital Holdings LLC’s holdings in Intuitive Surgical were worth $7,499,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of ISRG. Vanguard Group Inc. increased its holdings in shares of Intuitive Surgical by 1.4% in the 1st quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock valued at $16,178,258,000 after acquiring an additional 453,335 shares during the last quarter. Invesco Ltd. increased its holdings in shares of Intuitive Surgical by 1.7% in the 1st quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider’s stock valued at $2,090,027,000 after acquiring an additional 71,794 shares during the last quarter. Northern Trust Corp increased its holdings in shares of Intuitive Surgical by 0.3% in the 1st quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider’s stock valued at $1,798,465,000 after acquiring an additional 11,988 shares during the last quarter. Wellington Management Group LLP increased its holdings in shares of Intuitive Surgical by 15.0% in the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock valued at $1,732,975,000 after acquiring an additional 457,080 shares during the last quarter. Finally, Nuveen LLC purchased a new position in shares of Intuitive Surgical in the 1st quarter valued at about $1,715,899,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Myriam Curet sold 125 shares of the firm’s stock in a transaction on Wednesday, October 29th. The stock was sold at an average price of $543.00, for a total transaction of $67,875.00. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Gary S. Guthart sold 2,800 shares of the firm’s stock in a transaction on Friday, October 24th. The stock was sold at an average price of $546.27, for a total value of $1,529,556.00. Following the sale, the insider owned 17,120 shares in the company, valued at $9,352,142.40. This trade represents a 14.06% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 96,011 shares of company stock valued at $50,309,042. 0.70% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of brokerages recently issued reports on ISRG. Sanford C. Bernstein reissued an “outperform” rating and issued a $685.00 target price on shares of Intuitive Surgical in a research report on Tuesday, October 21st. BTIG Research upped their target price on Intuitive Surgical from $529.00 to $589.00 and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Wells Fargo & Company upped their target price on Intuitive Surgical from $599.00 to $600.00 and gave the company an “overweight” rating in a research report on Wednesday, October 22nd. Leerink Partners increased their price objective on Intuitive Surgical from $593.00 to $600.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 22nd. Finally, Hsbc Global Res raised Intuitive Surgical to a “strong-buy” rating in a research report on Thursday, October 23rd. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $608.92.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $534.28 on Monday. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The company has a market capitalization of $191.53 billion, a P/E ratio of 70.67, a PEG ratio of 4.94 and a beta of 1.61. The business has a 50 day moving average price of $464.32 and a 200 day moving average price of $498.73.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. During the same quarter last year, the firm earned $1.84 earnings per share. The business’s revenue was up 22.9% on a year-over-year basis. On average, research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.